Recent News

Share
and/or
541 News Items found
pancreatic surgeon and K12 alum Vinod Balachandran
MSK Program Prepares Clinicians for Careers in Translational Cancer Research
In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer
Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
MSK molecular geneticist Elli Papaemmanuil
Improved Scoring System for Myelodysplastic Syndromes Could Help Doctors Tailor Treatment
The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control
Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer
The findings could pave the way toward more targeted treatments for the disease.
Event
GSK dean and graduates in their caps and gowns
MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners
At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
Gerstner Sloan Kettering Students
8 Gerstner Sloan Kettering Students Prepare To Graduate
Eight scientists are poised to receive their doctorates and embark on careers tackling problems in human disease through biomedical research. Their years of dedication and training will be recognized on May 18, 2022, when they will be awarded their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK). This year’s commencement marks the school’s 11th graduating class since admitting its first students in 2006.
Dan Heller
A Sensor Sniffs for Cancer, Using Artificial Intelligence
By detecting molecular signatures in the blood, the sensor may help improve cancer screenings.
SKI immunologist Ming Li
SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy
The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.